Dispelling Myths in the Value vs. Growth Debate with GMO's Ben Inker

After years of struggle, it seemed like the big rebound value investors had been waiting for was upon us in the wake of the 2020 bear market. But recent months have seen a return to the dominance of growth, which has many investors believing value's rebound was nothing more than a head fake. This week, we are joined by GMO Head of Asset Allocation Ben Inker to discuss the recent quarterly letter he wrote to counter these arguments. We discuss the common arguments investors are making against value and why they may not hold up when subjected to scrutiny. We also get Ben's thoughts on a variety of other issues including factor timing, the future of the 60-40 portfolio and how the current period value compares to the period in the early 2000s.   We hope you enjoy the discussion.   ABOUT THE PODCAST Excess Returns is an investing podcast hosted by Jack Forehand (@practicalquant) and Justin Carbonneau (@jjcarbonneau), partners at Validea. Justin and Jack discuss a wide range of investing topics including factor investing, value investing, momentum investing, multi-factor investing, trend following, market valuation and more with the goal of helping those who watch and listen become better long term investors. SEE LATEST EPISODES https://www.validea.com/excess-returns-podcast FIND OUT MORE ABOUT VALIDEA https://www.validea.com FOLLOW OUR BLOG https://blog.validea.com FIND OUT MORE ABOUT VALIDEA CAPITAL https://www.valideacapital.com FOLLOW JACK Twitter: https://twitter.com/practicalquant LinkedIn: https://www.linkedin.com/in/jack-forehand-8015094 FOLLOW JUSTIN Twitter: https://twitter.com/jjcarbonneau LinkedIn: https://www.linkedin.com/in/jcarbonneau

There are no comments yet.

Please log in to write the first comment.